Evidence map›Paper›PMID 33000380›Full record

ArticleCerebellum (London, England)2021

Neuropsychiatric Symptoms as a Reliable Phenomenology of Cerebellar Ataxia.

Sharif I Kronemer, Mitchell B Slapik, Jessica R Pietrowski, Michael J Margron, Owen P Morgan, Catherine C Bakker, Liana S Rosenthal, Chiadi U Onyike, Cherie L Marvel

Open access · greenAbstract read
In one paragraph

Article in Cerebellum (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. The underpinnings of cerebellar ataxias.Clinical neurophysiology practice · 2022
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sharif I KronemerInterdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.
Mitchell B SlapikNeurology, Johns Hopkins University, Baltimore, MD, USA.
Jessica R PietrowskiNeurology, Johns Hopkins University, Baltimore, MD, USA.
Michael J MargronPsychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Owen P MorganNeurology, Johns Hopkins University, Baltimore, MD, USA.
Catherine C BakkerNeurology, Johns Hopkins University, Baltimore, MD, USA.
Liana S RosenthalNeurology, Johns Hopkins University, Baltimore, MD, USA.
Chiadi U OnyikePsychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
Cherie L MarvelNeurology, Johns Hopkins University, Baltimore, MD, USA. cmarvel1@jhmi.edu.ORCID http://orcid.org/0000-0002-2818-8303
Johns Hopkins University · USYale University · US

Funding

NEUROBIOLOGY OF CORTICAL SYSTEMST32NS007224 · NINDS · YALE UNIVERSITY · PI CARDIN, JESSICA A · 1985 to 2025
$4.6M
Gordon and Marylin Macklin Foundation noneJane Tanger Black Fund for Young-Onset Dementias noneMargaret Q. Landenberger Research Foundation noneNancy H. Hall Fund for Geriatric Psychiatry noneNINDS NIH HHS T32 NS007224
6 · The paper itself

Abstract

While cerebellar ataxia (CA) is a neurodegenerative disease known for motor impairment, changes in mood have also been reported. A full account of neuropsychiatric symptomology in CA may guide improvements in treatment regimes, measure the presence and severity of sub-clinical neuropsychiatric disturbance symptomology in CA, and compare patient versus informant symptom recognition. Neuropsychiatric phenomena were gathered from CA patients with genetic and unknown etiologies and their informants (e.g., spouse or parent). Information was obtained from in-person interviews and the Center for Epidemiologic Studies Depression Scale. Responses were converted to the Neuropsychiatric Inventory-Questionnaire (NPI-Q) scores by consensus ratings. Patient NPI-Q scores were evaluated for symptom prevalence and severity relative to those obtained from healthy controls. Patient-informant NPI-Q score disagreements were evaluated. In this cohort, 95% of patients presented with at least one neuropsychiatric symptom and 51% of patients with three or more symptoms. The most common symptoms were anxiety, depression, nighttime behaviors (e.g., interrupted sleep), irritability, disinhibition, abnormal appetite, and agitation. The prevalence of these neuropsychiatric symptoms was uniform across patients with genetic versus unknown etiologies. Patient and informant symptom report disagreements reflected that patients noted sleep impairment and depression, while informants noted irritability and agitation. Neuropsychiatric disturbance is highly prevalent in patients with CA and contributes to the phenomenology of CA, regardless of etiology. Clinicians should monitor psychiatric health in their CA patients, considering that supplemental information from informants can help gauge the impact on family members and caregivers.

Indexed as

AdultAgedAged, 80 and overCerebellar AtaxiaFemaleHumansMaleMental DisordersMiddle AgedAtaxiaCerebellar degenerationCerebellumMoodNeuropsychiatric

Identifiers

PMID33000380
PMCPMC9487161
OpenAlexW3090637356

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.